A review of bone scintigraphy in metastases from urological malignancies in adults;Le point sur la scintigraphie osseuse dans les cancers urologiques de l'adulte

Progres en Urologie

Volumn 18, Issue SUPPL. 7, 2008, Pages

  Vilain, D ^a   Hameg, A ^a   Tainturier, C ^a  

^a FOCH HOSPITAL   (France)

Author keywords

Bone metastasis; Bone scintigraphy; Diphosphonate; Prostate cancer

Indexed keywords

ADULT; ARTICLE; BONE TUMOR; HUMAN; METASTASIS; PATHOLOGY; SCINTISCANNING; URINARY TRACT CANCER;

ADULT; BONE NEOPLASMS; HUMANS; UROLOGIC NEOPLASMS;

EID: 57449088617     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1166-7087(08)74543-3     Document Type: Article

References (19)

1. Cook Jr. G., and Fogelman I. Radioisotope an PET imaging of Bone Metastases. In: Jasmin C., Coleman R.E., Coia L.R., Capanna R., and Saillant G. (Eds). Textbook of Bone Metastasis (2005), Wiley, West Sussex, England 77-90
2. Sandler E.D., Parisi M.T., and Hattner R.S. Duration of etidronate effect demonstrated by serial bone scintigraphy. J Nucl Med 32 (1991) 1782-1784
3. Hommeyer S.H., Varney D.M., and Eary J.F. Skeletal nonvisualization in a bone scan secondary to intravenous etidronate therapy. J Nucl Med 33 (1992) 748-750
4. m. Can Assoc Radiol J 48 (1997) 199-202
5. Soloway M.S., Hardeman S.W., Hickey D., Raymond J., Todd B., Soloway S., et al. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer 61 (1988) 195-202
6. Noguchi M., Kikuchi H., Ishibashi M., and Noda S. Percentage of the positive area of bone metastasis is an independent predictor of disease death in advanced prostate cancer. Br J Cancer 88 (2003) 195-201
7. Yahara J., Noguchi M., and Noda S. Quantitative evaluation of bone metastases in patients with advanced prostate cancer during systemic treatment. BJU Int 92 (2003) 379-383
8. Strobel K., Burger C., Seifert B., Husarik D.B., Soyka J.D., and Hany T.F. Characterization of focal bone lesions in the axial skeleton: performance of planar bone scintigraphy compared with SPECT and SPECT fused with CT. AJR Am J Roentgenol 188 (2007) 467-474
9. Even-Sapir E., Metser U., Mishani E., Lievshitz G., Lerman H., and Leibovitch I. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med 47 (2006) 287-297
10. Utsunomiya D., Shiraishi S., Imuta M., Tomiguchi S., Kawanaka K., Morishita S., et al. Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT. Radiology 238 (2006) 264-271
11. Even-Sapir E., Metser U., Flusser G., Zuriel L., Kollender Y., Lerman H., Lievshitz G., Ron I., and Mishani E. Assessment of malignant skeletal disease:initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18Ffluoride PET/CT. J Nucl Med 45 (2004) 272-278
12. Abuzallouf S., Dayes I., and Lukka H. Baseline staging of newly diagnosed prostate cancer: a summary of the literature. J Urol 171 (2004) 2122-2127
13. Kosuda S., Yoshimura I., Aizawa T., Koizumi K., Akakura K., Kuyama J., et al. Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan. Cancer 94 (2002) 964-972
14. Ishizuka O., Tanabe T., Nakayama T., Kawakami M., Kinebuchi Y., and Nishizawa O. Prostate-specific antigen. Gleason sum and clinical T stage for predicting the need for radionuclide bone scan for prostate cancer patients in Japan. Int J Urol 12 (2005) 728-732
15. Soulié M., Beuzeboc P., Cornud F., Eschwege P., Gaschignard N., Grosclaude P., et al. Comité de Cancérologie de l'Association Française d'Urologie. Prostate Cancer. Prog Urol 17 (2007) 1159-1230
16. Méjean A., André M., Doublet J.D., Fendler J.P., de Fromont M., Hélénon O., et al. Comité de Cancérologie de l'Association Française d'Urologie:Kidney tumors. Prog Urol 14 (2004) 999-1035 997
17. Koga S., Tsuda S., Nishikido M., Ogawa Y., Hayashi K., Hayashi T., et al. The diagnostic value of bone scan in patients with renal cell carcinoma. J Urol 166 (2001) 2126-2128
18. Shvarts O., Lam J.S., Kim H.L., Han K.R., Figlin R., and Belldegrun A. Eastern Cooperative Oncology Group performance status predicts bone metastasis in patients presenting with renal cell carcinoma: implication for preoperative bone scans. J Urol 172 (2004) 867-870
19. Comité de Cancérologie de l'Association Française d'Urologie. Prostate Cancer. Prog Urol 2007; 17:1035-1158.